Try our mobile app

Oncocyte's VitaGraftTM Kidney Identifies Transplant Rejection 10 Months Earlier

Published: 2023-09-18 12:00:00 ET
<<<  go to OCX company page

Interventional study compares VitaGraft to current transplant rejection monitoring protocols

Oncocyte's VitaGraft assay detects antibody-mediated transplant rejection 10 months sooner than commonly used monitoring protocols (p